Filing Details

Accession Number:
0000950170-23-057640
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-01 18:21:11
Reporting Period:
2023-10-30
Accepted Time:
2023-11-01 18:21:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501796 Aura Biosciences Inc. AURA Biological Products, (No Disgnostic Substances) (2836) 320271970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1889633 Elisabet Pinos Los De C/O Aura Biosciences, Inc.
80 Guest Street
Boston MA 01235
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-10-30 9,586 $6.83 180,940 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 131,412 Indirect By EdIP Revocable Trust
Footnotes
  1. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.